| Choosing the appropriate sclerosing concentration for vessel diameter. | |
| | |
MedLine Citation:
|
PMID: 20590703 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
With the development of novel sclerosing solutions, there has been an increase of choice in which sclerosant to utilize for a particular varicosity. It is not only important for the practitioner to define which sclerosant may be effective in a given clinical scenario, but also identify the minimal sclerosant concentration (MSC) that will produce effective results. This article will overview the salient points of choosing the appropriate sclerosant as well as review which MSC to choose based on patient profile, physician experience, FDA recommendations, and vessel diameter to maximize clinical outcomes while decreasing adverse effects. |
| | |
Authors:
|
Neil S Sadick |
Related Documents
:
|
15707133 - Artificial disc replacement: the new solution for discogenic low back pain? 20083783 - Diagnostic contributions of videolaryngostroboscopy in the pediatric population. 12190163 - Urinary trypsinogen activation peptide is more accurate than hematocrit in determining ... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] Volume: 36 Suppl 2 ISSN: 1524-4725 ISO Abbreviation: Dermatol Surg Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-07-01 Completed Date: 2010-08-12 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9504371 Medline TA: Dermatol Surg Country: United States |
Other Details:
|
Languages: eng Pagination: 976-81 Citation Subset: IM |
Affiliation:
|
Department of Dermatology, Weill Medical College, Cornell University, New York, New York, USA. nssderm@sadickdermatology.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aftercare Decision Making Detergents / administration & dosage, adverse effects Humans Irritants / administration & dosage, adverse effects Microbubbles Sclerosing Solutions / administration & dosage*, adverse effects Sclerotherapy / methods* Telangiectasis / pathology, therapy* Varicose Veins / pathology, therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Detergents; 0/Irritants; 0/Sclerosing Solutions |
| Comments/Corrections | |
Comment In:
|
Dermatol Surg. 2010 Jun;36 Suppl 2:982
[PMID:
20590704
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Ph...
Next Document: Review of published information on foam sclerotherapy.